Registry Study of Medical Therapy in Patients With Angina Pectoris(GREAT)

Status Completed

Clinical Trial Summary

The study will be a multi-center, prospective, cohort study based on registration of Chinese angina pectoris patients. After signing the informed consent, all patients will be screened as per the inclusion and exclusion criteria. Estimated 1500 eligible patients will be enrolled. Two natural cohort will be formed according to whether Nicorandil will be prescribed to patients or not. The baseline information of patients will be recorded and patients will be followed up to observe the effectiveness of different anti-angina regimens. Follow-up visits will be conducted at Month 3, 6, 9, 12 after enrollment. The visits at Months 3, 6 and 9 will be conducted in the form of electronic patient reported outcomes (ePRO) + telephone follow-up, and the visit at Month 12 will be conducted on site. Patients are required to fill in the patient diary records (weekly) during the course of the study. This study is designed to establish a cohort of Chinese angina pectoris patients and compare the effectiveness of different anti-angina regimens in patients with angina pectoris.

Clinical Trial Description

After having signed informed consent (Day 0), the patients will be screened for enrollment. About 1500 eligible patients will be enrolled in this study. The basic information of eligible patients including demographic characteristics, history of present illness, past history, Rose questionnaire, vital sign, medication information, SAQ and other optional examination data will be collected at Day 0. At Day 0, the patients will join the study Wechat Mini Program developed for online follow up and patient education by scan the QR code provided by investigators. After enrollment, the following information will be collected by ePRO with WeChat Mini Program or telephone follow up of month 3, 6 and 9: vital sign, medication information, SAQ, AE. The follow up of month 12 will be conducted on site which will collect SAQ, AE and other optional examination data. ;

Study Design

Related Conditions & MeSH terms

Angina Pectoris

Clinical Trial Details

NCT number	NCT05050773
Study type	Observational [Patient Registry]
Source	Beijing Anzhen Hospital
Contact
Status	Completed
Phase
Start date	September 13, 2021
Completion date	June 10, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05563701` - Evaluation of the LVivo Image Quality Scoring (IQS)
Recruiting	`NCT02773615` - CT Perfusion Added to CT Angiography
Active, not recruiting	`NCT04475380` - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Terminated	`NCT02548611` - Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention	Phase 4
Completed	`NCT02264717` - Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease	N/A
Completed	`NCT02440893` - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Completed	`NCT01425359` - Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina	Phase 4
Completed	`NCT01486030` - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Completed	`NCT01604486` - Natural Ischaemic Preconditioning Before First Myocardial Infarction	N/A
Completed	`NCT00811772` - Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis	N/A
Completed	`NCT00131183` - Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina	Phase 4
Completed	`NCT00184444` - Effect of Increased Oxygenation in the Air During Endurance Training in Stable Angina Pectoris Patients	N/A
Completed	`NCT00235404` - Randomized Controlled Trial of Health Care to Elderly Patients.	N/A
Terminated	`NCT00157742` - Comparison of SCS and PMR in Patients With Refractory Angina Pectoris	Phase 4
Completed	`NCT00000510` - Platelet-Inhibitor Drug Trial in Coronary Angioplasty	Phase 3
Completed	`NCT00005148` - Coronary Heart Disease Incidence, Mortality, and Risk Factor Relationships	N/A
Not yet recruiting	`NCT03657758` - Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]	Phase 4
Completed	`NCT00093223` - A Safety Study of ABI-007 for In-Stent Restenosis	Phase 2
Active, not recruiting	`NCT02508714` - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents	N/A
Recruiting	`NCT02623569` - To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina	Phase 2